Table 2.

Correlations between 14-3-3σ expression in cancer tissues and the clinicopathologic variables of the patients

Clinical variables	Sample No.	14-3-3 σ IRS in cancer tissue (%)				P-value
		0	1	2	3
Stage						P = 0.855†
I	20	6 (30.0)	5 (25.0)	5 (25.0)	3 (15.0)
II-III	20	8 (40.0)	3 (15.0)	6 (30.0)	4 (20.0)
Grade						P = 0.001‡
Well	7	0 (0)	0 (0)	2 (28.6)	5 (71.4)
Moderate	18	6 (33.3)	5 (27.8)	6 (33.3)	1 (5.6)
Poor	15	8 (53.3)	3 (20.0)	3 (20.0)	1 (6.7)
Risk						P = 0.003§
Low risk	13	1 (7.7)	2 (15.4)	6 (46.1)	4 (30.8)
High risk	11	5 (45.5)	4 (36.4)	2 (18.1)	0 (0)

^†Stage, I versus II-III (P-value from Mann-Whitney U test).

^‡Differentiation grade, well versus moderate versus poor (P-value from Kruskal-Wallis test).

^§Risk, low risk versus high risk (P-value from Mann-Whitney U test). IRS, immunoreactivity scoring.